The Column Group Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
27
- Investments
-
127
- Portfolio
-
26
- Exits
-
29
The Column Group General Information
Company Description
Founded in 2007, The Column Group is a venture capital investment firm based in San Francisco, California. The firm prefers to invest in seed-stage and early-stage companies operating in healthcare, life sciences, oncology, drug discovery, and technology-based sectors in the United States. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.thecolumngroup.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 1 Letterman Drive, Building D
- Suite DM-900
- San Francisco, CA 94129
- United States
The Column Group Investments (127)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Tortugas Neuroscience | 01-Jun-2025 | Early Stage VC | Drug Discovery | Startup | ||
| Neurona Therapeutics | 28-Mar-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Surrozen | 24-Mar-2025 | Drug Discovery | Pre-Clinical Trials | |||
| Eikon Therapeutics | 26-Feb-2025 | Drug Discovery | Generating Revenue | |||
| Cajal Neuroscience | 04-Feb-2025 | Drug Discovery | Generating Revenue | |||
| Circle Pharma | 10-Jan-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| A2 Bio | 09-Jan-2025 | Biotechnology | Clinical Trials - Phase 1 | |||
| Topo Therapeutics | 31-Dec-2024 | Drug Discovery | Startup | |||
| RAPT Therapeutics | 27-Dec-2024 | PIPE | Drug Discovery | Generating Revenue | ||
| Judo Bio | 07-Oct-2024 | Early Stage VC | Drug Discovery | Pre-Clinical Trials |
The Column Group Exits (29)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Ribon Therapeutics | 05-Aug-2024 | Out of Business | |
| Escient Pharmaceuticals | 30-May-2024 | ||
| Carmot Therapeutics | 26-Jan-2024 | ||
| Sagimet Biosciences | 14-Jul-2023 | ||
| Effector Therapeutics | 25-Aug-2021 | ||
| Tenaya Therapeutics | 30-Jul-2021 | ||
| Constellation Pharmaceuticals | 15-Jul-2021 | ||
| Nurix Therapeutics | 05-Mar-2021 | ||
| ORIC Pharmaceuticals | 13-Nov-2020 | Public Investment 2nd Offering | |
| Nurix Therapeutics | 24-Jul-2020 | IPO |
The Column Group Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
The Column Group Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
The Column Group Co-Investors (135)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Euclidean Capital | 9 |
|
|
||
| Alexandria Venture Investments |
|
|
|||
| Lux Capital |
|
|
|||
| Casdin Capital |
|
|
|||
| RA Capital Management |
|
|
The Column Group FAQs
-
What is The Column Group?
Founded in 2007, The Column Group is a venture capital investment firm based in San Francisco, California.
-
When was The Column Group founded?
The Column Group was founded in 2007.
-
Where is The Column Group headquartered?
The Column Group is headquartered in San Francisco, CA.
-
What is The Column Group's total asset value?
The Column Group has around in total assets under management.
-
How many investments has The Column Group made?
The Column Group has made 127 investments.
-
What has The Column Group invested in?
The Column Group has made numerous investments in companies like Tortugas Neuroscience, Neurona Therapeutics, and Surrozen within the Drug Discovery industry.
-
What has The Column Group invested in recently?
The Column Group's latest investment was on 01-Jun-2025 in Tortugas Neuroscience, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
